Literature DB >> 16766266

Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.

Ian J Davis1, Jessica J Kim, Fatih Ozsolak, Hans R Widlund, Orit Rozenblatt-Rosen, Scott R Granter, Jinyan Du, Jonathan A Fletcher, Christopher T Denny, Stephen L Lessnick, W Marston Linehan, Andrew L Kung, David E Fisher.   

Abstract

Clear cell sarcoma (CCS) harbors a pathognomonic chromosomal translocation fusing the Ewing's sarcoma gene (EWS) to the CREB family transcription factor ATF1 and exhibits melanocytic features. We show that EWS-ATF1 occupies the MITF promoter, mimicking melanocyte-stimulating hormone (MSH) signaling to induce expression of MITF, the melanocytic master transcription factor and an amplified oncogene in melanoma. Knockdown/rescue studies revealed that MITF mediates the requirement of EWS-ATF1 for CCS survival in vitro and in vivo as well as for melanocytic differentiation. Moreover, MITF and TFE3 reciprocally rescue one another in lines derived from CCS or pediatric renal carcinoma. Seemingly unrelated tumors thus employ distinct strategies to oncogenically dysregulate the MiT family, collectively broadening the definition of MiT-associated human cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766266     DOI: 10.1016/j.ccr.2006.04.021

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  56 in total

Review 1.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

Review 2.  The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.

Authors:  Akinori Kawakami; David E Fisher
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

Review 3.  Advances in sarcoma genomics and new therapeutic targets.

Authors:  Barry S Taylor; Jordi Barretina; Robert G Maki; Cristina R Antonescu; Samuel Singer; Marc Ladanyi
Journal:  Nat Rev Cancer       Date:  2011-07-14       Impact factor: 60.716

4.  Coordinated but physically separable interaction with H3K27-demethylase and H3K4-methyltransferase activities are required for T-box protein-mediated activation of developmental gene expression.

Authors:  Sara A Miller; Albert C Huang; Michael M Miazgowicz; Margaret M Brassil; Amy S Weinmann
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

Review 5.  Clear cell sarcoma-A review.

Authors:  Rami Mossad Ibrahim; Signe Steenstrup Jensen; Jacob Juel
Journal:  J Orthop       Date:  2018-09-06

6.  Regulation of MITF stability by the USP13 deubiquitinase.

Authors:  Xiansi Zhao; Brian Fiske; Akinori Kawakami; Juying Li; David E Fisher
Journal:  Nat Commun       Date:  2011-08-02       Impact factor: 14.919

7.  A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).

Authors:  James I Geller; John P Perentesis; Xiaowei Liu; Charles G Minard; Rachel A Kudgus; Joel M Reid; Elizabeth Fox; Susan M Blaney; Brenda J Weigel
Journal:  Pediatr Blood Cancer       Date:  2017-04-27       Impact factor: 3.167

8.  Translocation renal cell carcinomas in adults: a single-institution experience.

Authors:  Minghao Zhong; Patricia De Angelo; Lisa Osborne; Alberto E Paniz-Mondolfi; Matthew Geller; Youfeng Yang; W Marston Linehan; Maria J Merino; Carlos Cordon-Cardo; Dongming Cai
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

9.  Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.

Authors:  Erez Feige; Satoru Yokoyama; Carmit Levy; Mehdi Khaled; Vivien Igras; Richard J Lin; Stephen Lee; Hans R Widlund; Scott R Granter; Andrew L Kung; David E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

10.  mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads.

Authors:  Minoru Kitago; Kazuo Koyanagi; Takeshi Nakamura; Yasufumi Goto; Mark Faries; Steven J O'Day; Donald L Morton; Soldano Ferrone; Dave S B Hoon
Journal:  Clin Chem       Date:  2009-02-20       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.